Edwards Lifesciences Corporation Proceeds from Long-Term Debt Issued
Edwards Lifesciences Corporation (EW) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2024-02-12
- Edwards Lifesciences Corporation proceeds from issuance of long-term debt for the quarter ending 2022-12-31 was $0.00.
- Edwards Lifesciences Corporation proceeds from issuance of long-term debt for the quarter ending 2022-09-30 was $0.00.
- Edwards Lifesciences Corporation proceeds from issuance of long-term debt for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation proceeds from issuance of long-term debt for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation proceeds from issuance of long-term debt for fiscal 2023 was $0.00.
- Edwards Lifesciences Corporation proceeds from issuance of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Edwards Lifesciences Corporation proceeds from issuance of long-term debt for fiscal 2021 was $5.20M, a 67.90% decline from fiscal 2020.
- Edwards Lifesciences Corporation proceeds from issuance of long-term debt for fiscal 2020 was $16.20M, a 14.29% decline from fiscal 2019.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-12 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $0.00 derived: sum of 2 quarters · filed 2024-02-12 | $0.00 derived: sum of 3 quarters · filed 2024-02-12 | $0.00 10-K · filed 2024-02-12 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $0.00 derived: sum of 2 quarters · filed 2022-10-28 | $0.00 10-Q · filed 2022-10-28 | $0.00 derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $0.00 10-Q · filed 2022-07-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-12 | -$8.80M derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-03-31 | $0.00 10-Q · filed 2022-04-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-12 | -$8.80M derived: sum of 3 quarters · filed 2024-02-12 | $700.00K derived: sum of 4 quarters · filed 2024-02-12 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | -$8.80M derived: sum of 2 quarters · filed 2024-02-12 | $700.00K derived: sum of 3 quarters · filed 2024-02-12 | $5.20M 10-K · filed 2024-02-12 |
| 2021-09-30 | -$8.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $700.00K derived: sum of 2 quarters · filed 2022-10-28 | $5.20M 10-Q · filed 2022-10-28 | $9.10M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $14.00M 10-Q · filed 2022-07-29 | $17.90M derived: sum of 3 quarters · filed 2023-02-13 | $19.60M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $4.50M 10-Q · filed 2022-04-28 | $8.40M derived: sum of 2 quarters · filed 2023-02-13 | $10.10M derived: sum of 3 quarters · filed 2023-02-13 | $12.80M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $5.60M derived: sum of 2 quarters · filed 2023-02-13 | $8.30M derived: sum of 3 quarters · filed 2023-02-13 | $16.20M 10-K · filed 2023-02-13 |
| 2020-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $4.40M derived: sum of 2 quarters · filed 2021-10-29 | $12.30M 10-Q · filed 2021-10-29 | $19.20M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $10.60M 10-Q · filed 2021-07-30 | $17.50M derived: sum of 3 quarters · filed 2022-02-14 | $19.80M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-03-31 | $7.90M 10-Q · filed 2021-04-28 | $14.80M derived: sum of 2 quarters · filed 2022-02-14 | $17.10M derived: sum of 3 quarters · filed 2022-02-14 | $23.10M derived: sum of 4 quarters · filed 2022-02-14 |
| 2019-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $9.20M derived: sum of 2 quarters · filed 2022-02-14 | $15.20M derived: sum of 3 quarters · filed 2022-02-14 | $18.90M 10-K · filed 2022-02-14 |
| 2019-09-30 | $2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $8.30M derived: sum of 2 quarters · filed 2020-10-26 | $12.00M 10-Q · filed 2020-10-26 | $13.60M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $9.70M 10-Q · filed 2020-07-27 | $11.30M derived: sum of 3 quarters · filed 2021-02-12 | $11.90M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $3.70M 10-Q · filed 2020-04-28 | $5.30M derived: sum of 2 quarters · filed 2021-02-12 | $5.90M derived: sum of 3 quarters · filed 2021-02-12 | $686.60M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $2.20M derived: sum of 2 quarters · filed 2021-02-12 | $682.90M derived: sum of 3 quarters · filed 2021-02-12 | $688.00M 10-K · filed 2021-02-12 |
| 2018-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $681.30M derived: sum of 2 quarters · filed 2019-10-25 | $686.40M 10-Q · filed 2019-10-25 | $691.80M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $680.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $685.80M 10-Q · filed 2019-07-26 | $691.20M derived: sum of 3 quarters · filed 2020-02-14 | $695.10M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $5.10M 10-Q · filed 2019-04-26 | $10.50M derived: sum of 2 quarters · filed 2020-02-14 | $14.40M derived: sum of 3 quarters · filed 2020-02-14 | $622.40M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $9.30M derived: sum of 2 quarters · filed 2020-02-14 | $617.30M derived: sum of 3 quarters · filed 2020-02-14 | $994.70M 10-K · filed 2020-02-14 |
| 2017-09-30 | $3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $611.90M derived: sum of 2 quarters · filed 2018-10-26 | $989.30M 10-Q · filed 2018-10-26 | $1.22B derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $608.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $985.40M 10-Q · filed 2018-07-27 | $1.21B derived: sum of 3 quarters · filed 2019-02-15 | $1.22B derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $377.40M 10-Q · filed 2018-04-27 | $606.30M derived: sum of 2 quarters · filed 2019-02-15 | $615.00M derived: sum of 3 quarters · filed 2019-02-15 | $621.20M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $228.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $237.60M derived: sum of 2 quarters · filed 2019-02-15 | $243.80M derived: sum of 3 quarters · filed 2019-02-15 | $253.50M 10-K · filed 2019-02-15 |
| 2016-09-30 | $8.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $14.90M derived: sum of 2 quarters · filed 2017-10-27 | $24.60M 10-Q · filed 2017-10-27 | $35.30M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $15.90M 10-Q · filed 2017-07-28 | $26.60M derived: sum of 3 quarters · filed 2018-02-16 | $34.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $9.70M 10-Q · filed 2017-04-28 | $20.40M derived: sum of 2 quarters · filed 2018-02-16 | $27.80M derived: sum of 3 quarters · filed 2018-02-16 | $33.70M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $10.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $18.10M derived: sum of 2 quarters · filed 2018-02-16 | $24.00M derived: sum of 3 quarters · filed 2018-02-16 | $31.40M 10-K · filed 2018-02-16 |
| 2015-09-30 | $7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $13.30M derived: sum of 2 quarters · filed 2016-10-28 | $20.70M 10-Q · filed 2016-10-28 | $26.70M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $5.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $13.30M 10-Q · filed 2016-07-29 | $19.30M derived: sum of 3 quarters · filed 2017-02-17 | $25.50M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $7.40M 10-Q · filed 2016-04-29 | $13.40M derived: sum of 2 quarters · filed 2017-02-17 | $19.60M derived: sum of 3 quarters · filed 2017-02-17 | $25.40M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $12.20M derived: sum of 2 quarters · filed 2017-02-17 | $18.00M derived: sum of 3 quarters · filed 2017-02-17 | $226.30M 10-K · filed 2017-02-17 |
| 2014-09-30 | $6.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $12.00M derived: sum of 2 quarters · filed 2015-10-29 | $220.30M 10-Q · filed 2015-10-29 | $820.20M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $5.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $214.10M 10-Q · filed 2015-07-29 | $814.00M derived: sum of 3 quarters · filed 2016-02-19 | $1.19B derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $208.30M 10-Q · filed 2015-04-29 | $808.20M derived: sum of 2 quarters · filed 2016-02-19 | $1.18B derived: sum of 3 quarters · filed 2016-02-19 | $1.35B derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $599.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $972.80M derived: sum of 2 quarters · filed 2016-02-19 | $1.14B derived: sum of 3 quarters · filed 2016-02-19 | $1.30B 10-K · filed 2016-02-19 |
| 2013-09-30 | $372.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $541.30M derived: sum of 2 quarters · filed 2014-10-31 | $705.10M 10-Q · filed 2014-10-31 | |
| 2013-06-30 | $168.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $332.20M 10-Q · filed 2014-08-04 | ||
| 2013-03-31 | $163.80M 10-Q · filed 2014-05-02 | |||
| 2012-12-31 | $407.00M 10-K · filed 2015-02-20 | |||
| 2011-12-31 | $526.10M 10-K · filed 2014-02-28 | |||
| 2010-09-30 | $28.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $216.80M 10-Q · filed 2010-11-08 | ||
| 2010-06-30 | $188.20M 10-Q · filed 2010-08-06 | |||
| 2009-09-30 | $30.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $129.30M 10-Q · filed 2010-11-08 | ||
| 2009-06-30 | $99.30M 10-Q · filed 2010-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |